Literature DB >> 30273206

Increased Activity Due to Fractures Does Not Significantly Affect the Accuracy of 68Ga-DOTATATE PET/CT in the Detection of Culprit Tumor in the Evaluation of Tumor-Induced Osteomalacia.

Jie Ding, Guilan Hu, Ling Wang, Fang Li, Li Huo.   

Abstract

OBJECTIVE: Ga-DOTATATE PET/CT is currently the most common imaging modality in localizing culprit tumors, which can result in tumor-induced osteomalacia (TIO). Fracture, which is one of the most common consequences of the TIO, can also lead to increased Ga-DOTATATE activity and potentially affect the accuracy of Ga-DOTATATE PET/CT imaging. The aim of this investigation is to evaluate whether the increased Ga-DOTATATE activity at the sites of the fracture will cause interpretation difficulty in the localizing the culprit tumor causing TIO.
METHOD: The images of Ga-DOTATATE PET/CT scan from a total of 54 patients who had multiple foci of increased Ga-DOTATATE PET/CT on PET/CT were retrospectively analyzed. Not only was the intensity of the activity on PET but also the appearance of the activity on CT taken into consideration when the interpretation of the images occurred. The results from imaging analysis were compared with the clinical chart record. All patients had tentative clinical diagnosis of TIO.
RESULTS: The causative tumors in 53 patients were eventually identified. In 1 patient, the causative tumor was not identified. Among the 53 patients with confirmed TIO, 52 tumors were accurately localized.
CONCLUSIONS: Mild activity at the sites of fracture is not a major challenging factor in the interpretation of Ga-DOTATATE PET/CT in the evaluation of TIO when both intensity on PET and morphology on CT were assessed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30273206     DOI: 10.1097/RLU.0000000000002290

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Extended Whole-body Ga-68 DOTATATE PET-CT in evaluating Tumour-Induced Osteomalacia: Case report and review of literature.

Authors:  Teik Hin Tan; Ew-Jun Chen; Ming Tsuey Chew; Ping Ching Chye; Ming Wong
Journal:  Nucl Med Mol Imaging       Date:  2021-04-19

2.  Head-to-Head Comparison of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in Patients With Tumor-Induced Osteomalacia: A Prospective Study.

Authors:  Guozhu Hou; Yuwei Zhang; Yu Liu; Peipei Wang; Weibo Xia; Xiaoping Xing; Li Huo; Fang Li; Hongli Jing
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

Review 3.  Ameloblastic Fibroodontoma of Mandible Causing Tumor Induced Osteomalacia: A Case Report with Review of 88 Phosphaturic Oral Neoplasms.

Authors:  Deepika Mishra; Harpreet Kaur; Ashu Seith Bhalla; Smita Manchanda; Jithin Sasikumar; Bhaskar Agarwal; Ajoy Roychoudhury
Journal:  Head Neck Pathol       Date:  2021-01-04

4.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

Review 5.  Detection Rate of Culprit Tumors Causing Osteomalacia Using Somatostatin Receptor PET/CT: Systematic Review and Meta-Analysis.

Authors:  Marie Meyer; Marie Nicod Lalonde; Nathalie Testart; Mario Jreige; Christel Kamani; Sarah Boughdad; Barbara Muoio; Fabio Becce; Niklaus Schaefer; Christian Candrian; Luca Giovanella; John O Prior; Giorgio Treglia; Martin Riegger
Journal:  Diagnostics (Basel)       Date:  2019-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.